These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 861376)

  • 1. Induction of serum stimulation and plasma cell proliferation during chemotherapy of multiple myeloma.
    Karp JE; Burke PJ; Humphrey RL
    Blood; 1977 Jun; 49(6):925-34. PubMed ID: 861376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timed sequential chemotherapy of cytoxan-refractory multiple myeloma with cytoxan and adriamycin based on induced tumor proliferation.
    Karp JE; Humphrey RL; Burke PJ
    Blood; 1981 Mar; 57(3):468-75. PubMed ID: 7006709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of proliferative and clonogenic tumor cells in multiple myeloma.
    Karp JE; Burke PJ; Saylor PL; Humphrey RL
    Cancer Res; 1984 Sep; 44(9):4197-200. PubMed ID: 6744329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of humoral regulators on proliferation and maturation of normal and leukemic cells.
    Karp JE; Burke PJ
    Cancer Res; 1976 May; 36(5):1674-9. PubMed ID: 1063598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma.
    Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R; Montecucco CM; Ciotti R; Girino M
    Cell Tissue Kinet; 1987 May; 20(3):311-8. PubMed ID: 3480077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow kinetic studies on three patients with myelomatosis. Indications for malignant proliferation within both the plasma cell and lymphoid cell compartments.
    Mellstedt H; Killander D; Pettersson D
    Acta Med Scand; 1977; 202(5):413-7. PubMed ID: 335796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.
    Vacca A; Ribatti D; Presta M; Minischetti M; Iurlaro M; Ria R; Albini A; Bussolino F; Dammacco F
    Blood; 1999 May; 93(9):3064-73. PubMed ID: 10216103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow angiogenesis and circulating plasma cells in multiple myeloma.
    Kumar S; Witzig TE; Greipp PR; Rajkumar SV
    Br J Haematol; 2003 Jul; 122(2):272-4. PubMed ID: 12846897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of drug cytotoxicity by recruitment of leukemic myeloblasts with humoral stimulation.
    Karp JE; Burke PJ
    Cancer Res; 1976 Oct; 36(10):3600-3. PubMed ID: 1066183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1).
    Greipp PR; Witzig TE; Gonchoroff NJ
    Am J Hematol; 1985 Nov; 20(3):289-92. PubMed ID: 3904417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early recruitment in the human myeloma cell population after cytostatic treatment.
    Pileri A; Bernengo MG; Boccadoro M; Conte P; Marinone C; Masera P
    Haematologica; 1976 Jun; 61(2):184-93. PubMed ID: 59682
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells.
    Massaia M; Attisano C; Peola S; Montacchini L; Omedé P; Corradini P; Ferrero D; Boccadoro M; Bianchi A; Pileri A
    Blood; 1993 Sep; 82(6):1787-97. PubMed ID: 8400233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of human myeloma cells from bone marrow aspirates in multiple myeloma and their proliferation and M-protein secretion in vitro.
    Iwato K; Kawano M; Asaoku H; Tanabe O; Tanaka H; Kuramoto A
    Blood; 1988 Aug; 72(2):562-6. PubMed ID: 3401594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derangement of DNA synthesis in erythroleukaemia. Normal deoxyuridine suppression and impaired thymidine incorporation in bone marrow culture.
    Das KC; Garewal G; Mohanty D
    Acta Haematol; 1980; 64(3):121-30. PubMed ID: 6778044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 dependence of advanced malignant plasma cell dyscrasias.
    Zhang XG; Bataille R; Widjenes J; Klein B
    Cancer; 1992 Mar; 69(6):1373-6. PubMed ID: 1540875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spindle cell lesion in the bone marrow.
    Guzman S; Kitahara S
    Blood; 2018 Sep; 132(10):1085. PubMed ID: 30190353
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of bone marrow sections, smears and immunohistological staining for immunoglobulin light chains in the diagnosis of benign and malignant plasma cell proliferations.
    Thiry A; Delvenne P; Fontaine MA; Boniver J
    Histopathology; 1993 May; 22(5):423-8. PubMed ID: 7688339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
    Millar BC; Bell JB; Montes A; Millar JL; Maitland JA; Treleaven J; Viner C; Gore M; McElwain TJ
    Br J Haematol; 1990 Jul; 75(3):366-72. PubMed ID: 2201402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.
    Sezer O; Niemöller K; Jakob C; Zavrski I; Heider U; Eucker J; Kaufmann O; Possinger K
    Ann Hematol; 2001 Oct; 80(10):598-601. PubMed ID: 11732871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.